Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited)

v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating Expenses:    
Research and development $ 578,309 $ 658,939
Research and development - related parties 216,684 47,718
General and administrative 4,008,852 2,969,151
General and administrative - related parties 5,261
Total Operating Expenses 4,803,845 3,681,069
Loss From Operations (4,803,845) (3,681,069)
Other (Expense) Income:    
Interest expense (11,556) (7,414)
Interest income - related parties 4,562
Change in fair value of derivative liabilities 53,323 5,230,114
Change in fair value of accrued issuable equity 17,520
Total Other Income, Net 41,767 5,244,782
(Loss) Income Before Income Taxes (4,762,078) 1,563,713
Income tax benefit
Net (Loss) Income (4,762,078) 1,563,713
Other Comprehensive Income (Loss):    
Foreign currency translation adjustments 663 (728,081)
Total Comprehensive (Loss) Income $ (4,761,415) $ 835,632
Basic and Diluted Net (Loss) Income per Common Share    
Basic (in Dollars per share) $ (1.27) $ 0.92
Diluted (in Dollars per share) $ (1.27) $ 0.92
Weighted Average Number of Common Shares Outstanding:    
Basic (in Shares) 3,747,145 1,702,997
Diluted (in Shares) 3,747,145 1,703,439